Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Respiratory Distress Syndrome 1Pneumonia, Viral 1Hodgkin Disease 1Cytokine Release Syndrome 1

Interventions

Cyclophosphamide 16fludarabine phosphate 13Peripheral Blood Stem Cell Transplantation 13Whole-Body Irradiation 10Cyclosporine 10Antilymphocyte Serum 9Melphalan 8Busulfan 8Mycophenolic Acid 7Filgrastim 6fludarabine 5Radiotherapy 5Methotrexate 5Etoposide 5Psychiatric Rehabilitation 4Methylprednisolone 4Cytarabine 4Carmustine 4Blood Specimen Collection 4thymoglobulin 3Therapeutics 3Rituximab 3Flow Cytometry 3Aprepitant 3Analgesia 3Tacrolimus 2Stem Cell Transplantation 2Proton Therapy 2Polymerase Chain Reaction 2Ondansetron 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hodgkin Disease × Lopinavir × Clear all
NCT01165645 2022-12-01

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Mayo Clinic

Phase NA Withdrawn
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡